Syntara Limited (ASX:SNT)
Australia · Delayed Price · Currency is AUD 0.0230
0.00 (0.00%)
Jul 10, 2026, 3:48 PM AEST
Syntara Market Cap
Syntara has a market cap or net worth of 45.12 million as of July 10, 2026. Its market cap has decreased by -47.61% in one year.
Market Cap
45.12M
Enterprise Value
34.61M
Revenue
7.50M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.02
Market Cap Chart
Since November 10, 2003, Syntara's market cap has decreased from 360.06M to 45.12M, a decrease of -87.47%. That is a compound annual growth rate of -8.75%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 10, 2026 | 45.12M | -21.02% |
| Dec 31, 2025 | 57.13M | -54.77% |
| Dec 31, 2024 | 126.33M | 660.10% |
| Dec 29, 2023 | 16.62M | -62.11% |
| Dec 30, 2022 | 43.86M | -30.29% |
| Dec 31, 2021 | 62.92M | 70.33% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Vita Life Sciences | 134.32M |
| Little Green Pharma | 57.40M |
| Medical Developments International | 45.63M |
| Peak Processing | 19.73M |
| Vitura Health | 18.56M |
| IDT Australia | 13.68M |
| Epsilon Healthcare | 8.56M |
| Argent BioPharma | 8.00M |